AnGes, Inc.

¥25.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4563Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (20.59%)
Div yield —
ROE (214.64%)
Biotechnology
Beta (5Y) 0.53
PE TTM —
TSR TTM (71.26%)
Mkt cap ¥10.13B
ROIC (165.12%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥26
5.93%
(56.48%)
Buy 10|1|5|7|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.57
0.62
0.65
0.71
10.84%
6.41%
4.49%
18.38%
Revenue¥M
811.7
813.3
804.0
785.1
17.70%
13.93%
9.24%
1.86%
Peers (US$64.32M)
Cap (US$)
PE
54.11M
23.09x
Capital
TTM
5Y
10Y
Leveragex
1.101
0.014
0.015
EBIT/Intx
0.782
0.075
0.071
Own earn%
35.67
(16.06)
(28.74)
Sh yield%
24.66
45.93
45.53
Owners
Insiders/Inst%
8.64
80.41
Short interest%
0.80
SBC / revenue%
1.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
12–17
$1 testx
—
Incr. ROIC%
7